DrugPatentWatch Database Preview
Details for Patent: 8,623,826
Email this page to a colleague
See Plans and PricingWhich drugs does patent 8,623,826 protect, and when does it expire?
Patent 8,623,826 protects AKYNZEO and is included in one NDA.
This patent has sixty-six patent family members in thirty-nine countries.
Summary for Patent: 8,623,826
| Title: | Compositions and methods for treating centrally mediated nausea and vomiting |
| Abstract: | Provided are methods for treating nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery, comprising the co-administration of netupitant, palonosetron and dexamethasone. |
| Inventor(s): | Trento; Fabio (Como, IT), Cantoreggi; Sergio (Cagiallo, CH), Rossi; Giorgia (Como, IT), Cannella; Roberta (Varese, IT), Bonadeo; Daniele (Varese, IT) |
| Assignee: | Helsinn Healthcare S.A. (Lugano/Pazallo, CH) |
| Application Number: | 13/077,462 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 8,623,826
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Helsinn Hlthcare | AKYNZEO | netupitant; palonosetron hydrochloride | CAPSULE;ORAL | 205718-001 | Oct 10, 2014 | RX | Yes | Yes | Start Trial | Start Trial | USE IN COMBINATION WITH DEXAMETHASONE IN ADULTS FOR THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING ASSOCIATED WITH INITIAL AND REPEAT COURSES OF CANCER CHEMOTHERAPY, INCLUDING, BUT NOT LIMITED TO, HIGHLY EMETOGENIC CHEMOTHERAPY | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,623,826
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 3083 | Start Trial | |||
| Australia | 2010320598 | Start Trial | |||
| Brazil | 112012011485 | Start Trial | |||
| Canada | 2778301 | Start Trial | |||
| China | 102655864 | Start Trial | |||
| China | 104856998 | Start Trial | |||
| China | 104856999 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
